Commercial molecular diagnostic methods in infectious diseases: keeping up with the pathogens

References

1. Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis 2004; 4:337–348 [View Article] [PubMed]
   [Google Scholar]
2. Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med 2020; 8:1192–1200 [View Article] [PubMed]
   [Google Scholar]
3. Medicines and Healthcare products Regulatory Agency Guidance on Legislation: Guidance on the Regulation of In Vitro Diagnostic Medical Devices in Great Britain 2023
   [Google Scholar]
4. Medical Devices Regulations 2002 (SI 2002 no 618, as amended) (UK MDR 2002).
5. Roche Diagnostics Field Safety Notice. SBN-RDS-MolecularLab-2022-008 v1; 2022
6. Landry ML, Owen M. Failure to detect Influenza A H1N1 highlights the need for multiple gene targets in influenza molecular tests. J Clin Microbiol 2023; 61:e0044823 [View Article] [PubMed]
   [Google Scholar]
7. Roche Diagnostics Field Safety Notice. SBN-RDS-MolecularLab-2022-008 v3. n.d accessed 20 November 2023
8. Seegene Inc Field Safety Notice. FSN-20221212-RP9801X. n.d accessed 14 December 2022
9. Jørgensen RL, Lerche CJ, Pedersen MS, Kirkby NS, Botnen AB et al. Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results. APMIS 2022; 130:612–617 [View Article] [PubMed]
   [Google Scholar]
10. Luminex Corporation Field Safety Notice. FSN-0004. n.d accessed 8 March 2024
11. Cogdale J, Kele B, Myers R et al. Influenza A(H1N2)v incident management team. A case of swine influenza A(H1N2)v in England, November 2023. Euro Surveill 2023; 29:2400002 [View Article]
    [Google Scholar]
12. Ripa T, Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill 2006; 11:E061109 [View Article] [PubMed]
    [Google Scholar]
13. Unemo M, Clarke IN. The Swedish new variant of Chlamydia trachomatis. Curr Opin Infect Dis 2011; 24:62–69 [View Article] [PubMed]
    [Google Scholar]
14. Whiley DM, Limnios A, Moon NJ, Gehrig N, Goire N et al. False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011. Euro Surveill 2011; 16:19874 [PubMed]
    [Google Scholar]
15. Eastick K, Winter A, Jamdar S. Identification of Neisseria gonorrhoeae isolates with a recombinant porA gene in Scotland, United Kingdom, 2010 to 2011. Euro Surveill 2012; 17:20101 [PubMed]
    [Google Scholar]
16. Golparian D, Johansson E, Unemo M. Clinical Neisseria gonorrhoeae isolate with a N. meningitidis porA gene and no prolyliminopeptidase activity, Sweden, 2011: danger of false-negative genetic and culture diagnostic results. Euro Surveill 2012; 17:20102 [PubMed]
    [Google Scholar]
17. Ison CA, Golparian D, Saunders P, Chisholm S, Unemo M. Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally. Sex Transm Infect 2013; 89:197–201 [View Article] [PubMed]
    [Google Scholar]
18. Arnold BJ, Huang IT, Hanage WP. Horizontal gene transfer and adaptive evolution in bacteria. Nat Rev Microbiol 2022; 20:206–218 [View Article] [PubMed]
    [Google Scholar]
19. Masirika LM, Udahemuka JC, Schuele L, Ndishimye P, Otani S et al. Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024. Euro Surveill 2024; 29:2400106 [View Article] [PubMed]
    [Google Scholar]